Wall Street
Price Targets

ORX Price Targets Summary
Orexo AB

Wall Street analysts forecast ORX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORX is 40.8 SEK with a low forecast of 40.4 SEK and a high forecast of 42 SEK.

Lowest
Price Target
40.4 SEK
162% Upside
Average
Price Target
40.8 SEK
165% Upside
Highest
Price Target
42 SEK
172% Upside
Orexo AB Competitors:
Price Targets
4578
Otsuka Holdings Co Ltd
16% Upside
APPH
Apontis Pharma AG
30% Upside
CIPLA
Cipla Ltd
12% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
11% Upside
000423
Dong-E-E-Jiao Co Ltd
30% Upside
TORNTPHARM
Torrent Pharmaceuticals Ltd
12% Upside
4506
Sumitomo Pharma Co Ltd
13% Downside
512
Grand Pharmaceutical Group Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
Orexo AB

For the last 8 years the compound annual growth rate for Orexo AB's revenue is -2%. The projected CAGR for the next 3 years is 10%.

-2%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Orexo AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Orexo AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORX's stock price target?
Price Target
40.8 SEK

According to Wall Street analysts, the average 1-year price target for ORX is 40.8 SEK with a low forecast of 40.4 SEK and a high forecast of 42 SEK.

What is Orexo AB's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Orexo AB's revenue is -2%. The projected CAGR for the next 3 years is 10%.

Back to Top